Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1/2 1

Status

Recruiting 2

Sponsor Class

OTHER 2NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Primary Malignant Peripheral Nerve Sheath Tumors 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Magnetic Resonance Spectroscopy 84Specimen Handling 83Cyclophosphamide 75pembrolizumab 64Radiotherapy 54Nivolumab 52fludarabine 44Cisplatin 40Biopsy 40Carboplatin 39Standard of Care 38Bevacizumab 32Dexamethasone 31Rituximab 29Gemcitabine 29venetoclax 27Surveys and Questionnaires 27Radiosurgery 27Radiation 27Temozolomide 26Practice Guidelines as Topic 26Paclitaxel 25Doxorubicin 25Blood Specimen Collection 25Cytarabine 24fludarabine phosphate 23Interviews as Topic 22atezolizumab 21Injections 20Capecitabine 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Vorinostat × 30 days × Clear all
NCT05848687 2026-06-03

TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II

Stanford University

Phase 1/2 Recruiting
90 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06693284 2026-05-29

A Window of Opportunity Trial of Mirdametinib Plus Vorinostat for NF1 Associated, H3K27 Trimethylation Deficient Malignant Peripheral Nerve Sheath Tumor [MPNST]

University of Minnesota

Phase EARLY_PHASE1 Recruiting
8 enrolled

Primary Malignant Peripheral Nerve Sheath Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡